RxDoctor Payments DataLook up a doctor →

Oksana Shlobin, MD

Critical Care Medicine · Falls Church, VANPI 1780610840

Payments from drug & device makers

$1,923,932in general payments, 2019–2025

Across 910 payments — averaging $2114.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$615K
  • Boehringer Ingelheim$572K
  • Regeneron$264K
  • United Therapeutics Corporation$174K
  • Actelion Pharmaceuticals US, Inc.$70K
  • Merck$65K
  • plus $164K from 33 others
$3,190in research payments, 2019–2025

Across 4 payments — averaging $797.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • United Therapeutics Corporation$3K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,923,932 in reported general payments places this provider in the 95th percentile of 174 critical care medicine providers in Virginia.

See all critical care medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$58,723
Medicare patients
251
Services billed
576

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other critical care medicine in Falls Church

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →